Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Vaccine Maker Stocks Fall
Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS
Pfizer stock and shares of other vaccine makers slumped Friday after President-elect Donald Trump tapped Robert F. Kennedy Jr., a widely known vaccine skeptic, to lead the Department of Health and Human Services.
Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS
Shares of vaccine makers lost ground Thursday, hit by news that President-elect Donald Trump was naming vaccine skeptic and former presidential hopeful Robert F. Kennedy Jr. as his pick to lead the U.
Vaccine maker stocks tumble after Trump picks RFK Jr. for health secretary
Shares of prominent vaccine makers plunged Thursday after President-elect Donald Trump announced his pick of Robert F. Kennedy Jr. to be the next secretary of the Department of Health and Human Services.
2h
Moderna, with aid of TBWA\Chiat\Day, is making mRNA science exciting & accessible
With the help of TBWA\Chiat\Day New York, pharma giant Moderna is demystifying mRNA science for the average consumer. This ...
Los Angeles Times
1h
Health stocks slide as Trump picks vaccine skeptic Kennedy
Kennedy Jr. to run the Department of Health and Human Services, potentially elevating a prominent
vaccine
skeptic and ...
FiercePharma
7h
Vaccine stocks sag in US, Europe after RFK Jr.'s HHS appointment
“I just want to be sure every American knows the safety profile, the risk profile, and the efficacy of each
vaccine
,” RFK ...
18h
Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official
Vaccine stocks slid late Thursday as reports stated noted anti-vaccine politician Robert Kennedy Jr. will serve as the next ...
8d
Moderna reports surprise profit on higher-than-expected COVID vaccine sales
Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...
4d
Cautious Outlook on Moderna: Declining Vaccine Demand and Strategic Challenges Prompt Sell Rating
Leerink Partners analyst Mani Foroohar assigned a Sell rating on Moderna (MRNA – Research Report) on November 7 and set a price target of ...
1d
Could vaccine for winter vomiting bug be near?
There is currently no licensed vaccine for norovirus – commonly known as the winter vomiting bug – but are scientists getting ...
7d
Canada approves Moderna's RSV vaccine for adults aged 60 and older
Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
2024 U.S. Elections
The latest news on national races.
See more
Related topics
Robert F. Kennedy Jr.
Trump
HHS
Feedback